Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UKResearch Published on 2022-01-142022-10-28 Journal: BMC Pregnancy and Childbirth [Category] COVID-19, [키워드] age Analysis COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines driver ethnic group expressed facilitate health system information Intervention majority Multivariate analysis Pregnancy pregnant pregnant women promote Region reported response Result Safety significantly lower supplementary material Trust United Kingdom Vaccine were used white women [DOI] 10.1186/s12884-021-04321-3 PMC 바로가기 [Article Type] Research
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELYResearch Published on 2022-01-092022-10-28 Journal: The British Journal of General Practice [Category] COVID-19, SARS, [키워드] Administered Analysis approval black Care Clinical characteristics Cohort cohort study Committee conducted Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine demographic group Deprivation described England Ethnic groups General practice groups Health immunisation JCVI medical condition mental illness NHS NHS England OpenSAFELY Patient patients primary care recipient Result SARS-CoV-2 second dose secure subgroup the vaccine trend vaccination Vaccine Variation white [DOI] 10.3399/BJGP.2021.0376 PMC 바로가기 [Article Type] Research
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohortObservational Study Published on 2022-01-012022-10-05 Journal: Thorax [Category] SARS, 임상, [키워드] 1.26 95% CI Analysis approach association clinical epidemiology Cohort COVID-19 COVID-19-related death death deaths Eligible participants Evidence genetic instrument higher risk Hospital admission hospitalisation Infection infections inverse Mortality MOST MR analysis outcome Participants per day predicted primary care Public Health England questionnaire data randomisation reported risk risk of COVID-19 SARS-COV-2 infection SARS-CoV-2 testing data severe COVID-19 severity smoker smoking smoking status Support tobacco control. UK biobank was determined was used white [DOI] 10.1136/thoraxjnl-2021-217080 PMC 바로가기 [Article Type] Observational Study
Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients의료 시스템 및 지역 사회 기반 직원 및 환자 사이의 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)와 관련된 유병률, 분포 및 IgG 항체 수준Article Published on 2022-01-012022-09-12 Journal: The American journal of the medical sciences [Category] MERS, SARS, 진단, [키워드] 95% CIs 95% confidence interval Abbott American analyses Antibody test assistant association black BMI body mass index coronavirus 2 COVID-19 employee highest Hispanic IgG IgG antibodies IgG antibody IgG test Immunity Immunoglobulin Infection Level Logistic regression morbidity and mortality New Orleans Non-Hispanic Blacks not significant Nurse Odds ratio Older Other participant Participants Patient positive Prevalence prevalent relative respiratory SARS-CoV-2 Sex significantly more strong immune response tested threshold variable white women [DOI] 10.1016/j.amjms.2021.09.006 PMC 바로가기 [Article Type] Article
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19Randomized Controlled Trial Published on 2022-01-012022-10-05 Journal: Journal of substance abuse treatment [Category] SARS, 임상, [키워드] age baseline black Cluster Complete confounding variables COVID-19 COVID-19 pandemic disorder Disparities Disrupted eight enrolled Epidemic exacerbate group groups harm reduction Health Health inequity Hispanic Hypothesis indicated Inequity medication opioids participant pathway patients Person provided Racial randomized trial receiving reduced reduction Regression reported severity Sex Support tested Treatment used data white [DOI] 10.1016/j.jsat.2021.108648 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United StatesArticle Published on 2021-12-272022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] accounted age approach Asian black childhood children Community COVID-19 COVID-19 infection COVID-19 susceptibility COVID-19 vaccine demonstrated determinant Efficacy effort Emergency use Express FDA FDA approval finding General population Health disparities Health Science Hesitancy Hispanic Hospitalization indicate Intervention ordinal logistic regression parent parental parents participated pediatric pediatric vaccine hesitancy Pfizer-BioNTech Prevalence racial diversity recommendation SARS-CoV-2 severity Support the United State U.S. FDA urgency vaccinate Vaccine Vaccine hesitancy white [DOI] 10.3390/vaccines10010031 PMC 바로가기 [Article Type] Article
Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 PandemicResearch Published on 2021-12-232022-10-30 Journal: JAMA Health Forum [Category] COVID-19, [키워드] 95% CI affected aggregate all-cause mortality Analysis baseline beneficiary black Black patient Care changes in cohort study COVID-19 COVID-19 hospitalization COVID-19 mortality COVID-19 pandemic death discharge disparity driven by equity exposure finding greater group groups Health Hispanic Hispanic patient Hospitalization hospitalizations Importance in-hospital mortality increases in measure Medicare Mortality Non-COVID-19 not significantly different objective Older outcome pandemic participant Patient patients with COVID-19 Point Population populations race Racial Relevance Result robust secondary security setting tested unique white White patient White patients [DOI] 10.1001/jamahealthforum.2021.4223 PMC 바로가기 [Article Type] Research
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 PandemicResearch Published on 2021-12-222022-10-30 Journal: JAMA Psychiatry [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI accompanied age Ageing analyzed Anxiety anxiety symptom assessment Autonomy change changed changes changes in clinically cohort study Control COVID-19 COVID-19 pandemic Depression depressive symptom deteriorate Deterioration England English Evidence exposure finding Generalized greater group Health Immediate Importance increases in individual inequality initial introduced later phase less lockdown loneliness longitudinal longitudinal cohort study Los Angeles lowest measure Mental mental health mental health service National objective Older pandemic participant Participants pleasure Point poor quality Prevalence progressed provided psychological Impact Psychological intervention psychosocial stressor Quality of life regression models Relevance repeated Result Self-realization setting Sex significantly Sociodemographic characteristics Support tested the mean University of California Well-being white women [DOI] 10.1001/jamapsychiatry.2021.3749 PMC 바로가기 [Article Type] Research
Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021Research Article Published on 2021-12-212022-10-28 Journal: PLoS ONE [Category] COVID-19, SARS, [키워드] 95% CI 95%CI age black Contact COVID-19 COVID-19 vaccine decrease defined demographics difference evaluate exposure Facebook Factor Factors flu vaccine Gender Government groups Health status Hispanic identify Importance key factor lack less objective offered outcome measure participant Prevent reason reported response Result risk factor Safe Side effect survey the vaccine time vaccination rate Vaccine Vaccine hesitancy white yielding [DOI] 10.1371/journal.pone.0260731 PMC 바로가기 [Article Type] Research Article
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial영국에서 2 가지 용량의 Chadox1 NCOV-19 또는 BNT162B2에 따른 3 가지 용량 (부스터)으로서 7 개의 코비드 -19 백신의 안전성 및 면역 원성Clinical Trial Published on 2021-12-182022-08-13 Journal: Lancet (London, England) [Category] Fulltext, SARS, 임상, [키워드] 95% CI Ad26 Ad26.COV2.S adverse event age anti-Spike IgG antibody assigned blinded BNT BNT162b2 booster booster vaccination booster vaccines cellular response Cellular responses ChAd ChAdOx1 ChAdOx1 nCoV-19 Control control group control groups Course COV-BOOST COVID-19 COVID-19 vaccine CureVac CVn CVnCoV dose eligibility criteria ELISA female finding FIVE funding generate geometric mean geometric mean ratio geometric mean ratios GMR GMRs group humoral Humoral and cellular responses immunogenicity individuals initial intention-to-treat population investigated IQR ISRCTN janssen laboratory-confirmed SARS-CoV-2 infection Local m1273 median age MenACWY meningococcal conjugate vaccine Moderna modified intention-to-treat mRNA1273 multicentre neutralising response neutralising responses Novavax NVX NVX-CoV2373 Older Older age outcome Pain participant Participants Pfizer Phase 2 phase 2 trial primary analysis quadrivalent meningococcal conjugate vaccine randomised Randomly ranged reactogenicity referred to Registered Safety SARS-COV-2 infection screened secondary Secondary outcomes Serious Adverse Events Seven spike IgG systemic adverse events the median three group three groups treat treatment allocation Trial Vaccine vaccine availability Valneva Viral viral neutralisation VLA2001 were assessed were blinded white wild-type [DOI] 10.1016/S0140-6736(21)02717-3 PMC 바로가기 [Article Type] Clinical Trial